Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1999-5-20
pubmed:abstractText
We developed an experimental approach with genetically engineered and encapsulated mouse NIH 3T3 fibroblasts to delay the progressive degeneration of photoreceptor cells in dark-eyed Royal College of Surgeons rats. These xenogeneic fibroblasts can survive in 1. 5-mm-long microcapsules made of the biocompatible polymer AN69 for at least 90 days under in vitro and in vivo conditions because of their stable transfection with the gene for the 18-kDa form of the human basic fibroblast growth factor (hFGF-2). Furthermore, when transferred surgically into the vitreous cavity of 21-day-old Royal College of Surgeons rats, the microencapsulated hFGF-2-secreting fibroblasts provoked a local delay of photoreceptor cell degeneration, as seen at 45 days and 90 days after transplantation. This effect was limited to 2.08 mm2 (45 days) and 0.95 mm2 (90 days) of the retinal surface. In both untreated eyes and control globes with encapsulated hFGF-2-deficient fibroblasts, the rescued area (of at most 0.08 mm2) was significantly smaller at both time points. Although, in a few ocular globes, surgical trauma induced a reorganization of the retinal cytoarchitecture, neither microcapsule rejection nor hFGF-2-mediated tumor formation were detected in any treated eyes. These findings indicate that encapsulated fibroblasts secreting hFGF-2 or perhaps other agents can be applied as potential therapeutic tools to treat retinal dystrophies.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-1560052, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-2168521, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-2469690, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-5092207, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-7028675, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-7492705, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-7585554, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-7587305, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-7780086, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-8188463, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-8473122, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-8575338, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-8640564, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-9121555, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-9774635, http://linkedlifedata.com/resource/pubmed/commentcorrection/10077648-9858574
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3126-31
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats.
pubmed:affiliation
Centre de Recherches Thérapeutiques en Ophtalmologie, 156 Rue de Vaugirard, 75015 Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't